| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |